Why the study?
Heart failure requiring hospitalization increases the risk of mortality and rehospitalization, leading the ACC to publish an expert consensus decision pathway emphasizing a multidisciplinary approach.
This review highlights the integral role of hospital pharmacists in optimizing medical therapy and providing education for patients hospitalized with heart failure, based on the ACC Expert Consensus Decision Pathway.
Answers are grounded in this paper and cite their sources.
Supports pharmacist involvement in HF care teams; leaves open outcome impact without prospective trials.
Heart failure (HF) is a complex condition, and its clinical course often includes periods of decompensation that represent a deterioration in clinical status. During these periods, patients may experience worsening HF symptoms requiring hospitalization. Heart failure that necessitates hospitalization increases the risk of mortality and rehospitalization. In order to help facilitate appropriate care of patients hospitalized with HF, the American College Cardiology (ACC) published an expert consensus decision pathway (ECDP) that focuses on a multidisciplinary approach. The ECDP is divided into multiple nodes and pharmacists play integral roles in each one. There are many opportunities for pharmacists to optimize medical therapy, reinforce adherence, and provide medication and disease state education throughout hospitalization. This review article will highlight inpatient medication management of HF for hospital pharmacists.
No takes yet. Share an insight, caveat, or question.
Tellor et al. (2022) conducted a review in Heart failure. Inpatient medication management (ACC Expert Consensus Decision Pathway) was evaluated. This review highlights the integral roles of pharmacists in optimizing medical therapy, reinforcing adherence, and providing education for patients hospitalized with heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: